Search

Displaying results 1 - 10 of 11 in total
  1. Drug

    Orlistat

    go.drugbank.com/drugs/DB01083
    ApprovedInvestigational

    [A229928] Orlistat is a lipase inhibitor used in the treatment of obesity that works by inhibiting fat-metabolizing enzymes.

    Categories: orlistatSynonyms: Orlistat, Orlipastat
  2. Drug

    Glyceryl monocaprylate

    go.drugbank.com/drugs/DB19362
    Approved

    Synonyms: Oristar gcc
  3. Drug

    Ompenaclid

    go.drugbank.com/drugs/DB18819
    Investigational

    RGX-202 is a recombinant AAV8 that contains a vector genome encoding a miniaturized dystrophin protein (microdystrophin).

    Synonyms: Oristar gpa
  4. Drug

    Chitin

    go.drugbank.com/drugs/DB15142
    Investigational

    Shrimp shell chitin is under investigation in clinical trial NCT00863356 (Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis).

    Synonyms: ORISTAR CHITIN
  5. Indication

    Weight Gain

    go.drugbank.com/conditions/DBCOND0004465
    Drugs: Orlistat
  6. Indication

    Weight Reduction

    go.drugbank.com/conditions/DBCOND0043475
    Drugs: Orlistat · Topiramate
  7. Indication

    Weight Loss

    go.drugbank.com/conditions/DBCOND0029695
    Drugs: Dronabinol · Lysine · Orlistat · Ursodeoxycholic acid
  8. Indication

    Overweight

    go.drugbank.com/conditions/DBCOND0015946
    Drugs: Naltrexone · Orforglipron · Orlistat · Phentermine · Semaglutide · Topiramate
  9. Indication

    Caloric Restriction

    go.drugbank.com/conditions/DBCOND0006244
    Drugs: Naltrexone · Orforglipron · Orlistat · Semaglutide · Topiramate · alpha-Ketoisocaproic acid
  10. Drug

    GT 389-255

    go.drugbank.com/drugs/DB05894
    Experimental

    Peptimmune’s lead product GT 389-255, is a novel lipase inhibitor and fat binding hydrogel polymer conjugate for the treatment of obesity which has completed single and multiple ascending dose (SAD and MAD) Phase I trials. It is expected...